Mouse CXCL2 (GRO beta) Recombinant Protein, PeproTech

The University of Virginia awarded contract A207_PO-0483609 to Life Technologies Corporation on September 23, 2026. The cumulative contract value is $351. While specific details regarding the products and services to be delivered are not provided in the available contract documentation, Life Technologies Corporation's core business operations typically encompass life sciences research tools, reagents, instruments, and related consumables. The contracting organization, University of Virginia, is a research institution located in Virginia, and the contract likely supports research or laboratory operations at the university.

The contract documentation does not specify the period of performance, annual value breakdown, or detailed place of performance beyond the University of Virginia as the contracting organization. Given the minimal cumulative contract value of $351, this award likely represents a purchase order for limited quantities of laboratory supplies, reagents, or related consumables rather than a comprehensive service delivery contract. Without additional contract documentation detailing statement of work, specifications, or performance requirements, the precise scope of products and services cannot be determined from the information provided.